BrainStorm Receives US Notice of Allowance for its Key Stem Cell Technology … – PharmiWeb.com (press release)
|
BrainStorm Receives US Notice of Allowance for its Key Stem Cell Technology …
PharmiWeb.com (press release) BrainStorm Cell Therapeutics (OTC.QB: BCLI) a leading developer of adult stem cell technologies for neurodegenerative diseases today announced that it has received a Notice of Allowance from the U.S. Patent Office for its “Mesenchymal Stem Cells for … |
